
What would you do if you scrambled through that 3.5 hour window, only to find a colleague waiting with his foot stuck out?

What would you do if you scrambled through that 3.5 hour window, only to find a colleague waiting with his foot stuck out?

Approved in October 2013 for two patient groups, Riociguat (Adempas, Bayer) is a first-in-class sGC stimulator.

Compared to plasma, treatment with 4-factor PCC for warfarin reversal in patients with intracerebral hemorrhage does not seem to reduce 30-day all-cause mortality.

In the pharmacy, an array of foot-care products awaits patients who can't stand it anymore.

This case report underscored the importance of performing accurate genotyping before initiation of therapy.

Pharmacists who collaborate with ACOs can find many ways to exercise their skills and expand their knowledge. Partnerships are popping up everywhere, and so are the opportunities.

ISMP reports that a growing number of cases of oral vaccines intended to protect children against rotavirus gastroenteritis are mistakenly being injected.

Researchers have found a link between women who have taken oral contraceptives and an increased risk of multiple sclerosis (MS). However, this does not mean women should stop taking birth control.

Is your hospital ready? The emergency is here.

Myelita Melton is CEO of SpeakEasy Communications. With the ever-increasing Spanish-speaking population in the United States, Melton says either your pharmacy will find a way to better accommodate this group or your competitors will.

Dr. Reddy’s Laboratories has launched moxifloxacin HCl tablets, 400 mg, a therapeutic equivalent generic version of Avelox on March 4, following FDA approval.

In 2013, physician assistants, nurse practitioners, and others wrote nearly a third of the painkiller prescriptions issued, according to an investigation by the Milwaukee Journal Sentinel and Medpage Today.

Teva Pharmaceutical Industries launched loxapine inhalation powder, 10 mg (Adasuve) March 3, for the acute treatment of agitation associated with schizophrenia or bipolar 1 disorder in adults.

Pharmacy groups, representing more than 100,000 pharmacists in different pharmacy practice settings, have written to CMS Administrator Marilyn B. Tavenner to express their support for the expansion of medication therapy management (MTM) services to Medicare Part D beneficiaries in the CMS proposal released in early January.

The study concludes that AHA and other organizations should add depression to the official list of risk factors for acute coronary syndrome.

Claiming pharmacy benefit managers are trying to run them out of business, more than 100 Oklahoma independent pharmacists recently rallied at their state capitol.

Warfarin use may be safe following a heart attack in patients with both atrial fibrillation and chronic kidney disease, according to a Swedish study of more than 24,000 patients.

Leaders in ambulatory care pharmacy practice, medicine, and nursing met to draft recommendations to advance patient care in ambulatory settings.

Poor prescriber choices are setting patients up for for allergic reactions, super-resistant infections, and deadly diarrhea caused by C. difficile.

Long-term care pharmacists continued to push for support for provisions on short-cycle dispensing as the deadline for comments on the Centers for Medicare and Medicaid Service’s (CMS) proposed rule on Medicare Part D changes drew to a close on March 7.

Teen can buy generic morning-after contraceptive directly from OTC shelves without proving age.

Patients more than 80 years old are being “over-treated” for stroke prevention with statins and antihypertensive drugs, and doctors need to actively rethink their priorities and beliefs about stroke prevention, according to a new study published in Evidence Based Medicine.

FDA advisors decided against recommending over-the-counter (OTC) marketing approval of Primatene HFA inhaler (Armstrong Pharmaceuticals) for the temporary relief of mild symptoms of intermittent asthma in patients 12 years and older, at last week’s joint meeting of the FDA’s Nonprescription Drugs Advisory Committee and the Pulmonary-Allergy Drugs Advisory Committee.

Study finds similar levels of contamination by microorganisms on stethoscopes and physicians' dominant hands.

Check out the new and improved iPad app for Drug Topics! This app features tons of interactive content and a better way to view our magazine. All issues are completely free!

The DEA proposal to move hydrocodone combination products from Schedule III to Schedule II could have a major impact on pharmacies.

FDA has approved hyaluronic acid (HA) injection (Monovisc, Anika Therapeutics), a single-injection supplement to synovial fluid of the osteoarthritic joint, for the treatment of pain and the improvement of joint mobility in patients with osteoarthritis (OA) of the knee.

The National Association of Chain Drug Stores has endorsed a congressional proposal to establish a workgroup to collaborate on solutions to reduce prescription drug abuse and without comprising access to medications.

The Drug Enforcement Administration (DEA) has created a prescription drug abuse tip line in Georgia that will allow healthcare professionals and the public to anonymously report Rx abuse.

Health Mart launched its 2014 Healthy Living Tour during the Independent Pharmacy Business Growth Conference in Orlando, Fla. Pharmacists and other healthcare professionals will visit more than 130 communities across the United States providing health education and free health screenings.